Peter Krajci
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect on QTc interval by switching from methadone to equipotent R-methadone dose in methadone maintenance treatment patients.
Journal: Basic & clinical pharmacology & toxicology
Published: October 10, 2023
Concentrations of psychoactive substances in blood samples from non-fatal and fatal opioid overdoses.
Journal: British journal of clinical pharmacology
Published: September 03, 2021
Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone.
Journal: Addiction (Abingdon, England)
Published: May 29, 2020
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial.
Journal: European addiction research
Published: February 18, 2019
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.
Journal: JAMA psychiatry
Published: December 20, 2018
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study.
Journal: The American journal on addictions
Published: June 19, 2018
The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone®) in a Low Threshold Setting.
Journal: European addiction research
Published: May 24, 2018
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial.
Journal: Addiction (Abingdon, England)
Published: November 07, 2017
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Journal: JAMA psychiatry
Published: October 20, 2017
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.
Journal: European journal of gastroenterology & hepatology
Published: September 16, 2017
Buprenorphine dosing choices in specific populations: review of expert opinion.
Journal: Expert opinion on pharmacotherapy
Published: July 05, 2016
Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience.
Journal: Journal of public health (Oxford, England)
Published: October 29, 2015
Last Updated: 09/26/2026